Company identity
Company number 00446897
Company profile
UK company 00446897, incorporated on 19 December 1947.
Philips Electronics UK Limited is a UK company with status Active founded in 1947 based in South East England.
Company number 00446897
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jun 2020 to 31 Oct 2020
The World Health Organization has recognised Greater Manchester as the UK's first age-friendly city-region. As our population ageing, we need to move faster to create and shape GM as a test bed and vibrant market place for innovators to develop and deploy their products and services to support residents in our communities and neighbourhoods. The Internati...
1 Feb 2019 to 31 Mar 2023
"iCAIRD will be a Scottish centre of excellence, centred at the Queen Elizabeth University Hospital in Glasgow but with sites across Scotland, to enable joined up academic and commercial technology development and research, locally and nationally. Making use of the capability of modern computers to process the large amounts of data gathered in healthcare ...
1 Jan 2019 to 31 Mar 2023
"PathLEAD (**Path**ology data **L**akes, **E**ducation, **A**nalytics and **D**iscovery) is a consortium of nationally leading experts from the teaching hospitals of Coventry, Belfast, Nottingham and Oxford, their associated Universities and Philips, the commercial partner. We will develop computer aided diagnostics for testing of pathology samples. Speci...
1 Sep 2015 to 29 Feb 2016
Currently circular economy business models are not common practice within the UK healthcare sector, yet many other countries have already benefited from a shift away from the traditional linear value chain. Axion will work with Philips, a world leader in the supply of medical imaging systems and therapy devices, to investigate how a circular economy busin...
1 Apr 2014 to 31 Dec 2017
The goal of the proposed project is to develop a novel tool for atherosclerosis risk stratification. Cardiovascular disease (CVD) (especially, coronary artery disease and stroke) is the leading single cause of morbidity and mortality in the Western world. Vascular atherosclerotic disease is a causative factor in a high percentage of CVD events. Widely acc...
1 Oct 2013 to 30 Sep 2017
This SBRI Phase II proposal is to establish the necessary knowledge from the planned clinical studies and economic modelling to prove that an innovative technology: home tele-monitoring using white blood cell (WBC) count point of care technology (POCT) can help improve the care pathway and patient experience of people with cancer patients on chemotherapy....
1 Sep 2012 to 31 Mar 2015
To develop methods to link patient events and outcomes obtained from clinical datasets, to inform decision support rules and accelerate uptake of emerging diagnostic platforms.
1 Oct 2009 to 30 Jun 2012
Project Hydra is designed to bridge the gap between smart metering and telecare, exploring ways to utilise the same infrastructure and investment to deliver two key benefits to the UK population for a single cost. Governments globally are setting roll-out targets for smart meters, resulting in a new communications path to every home. In an innovative appr...
1 Sep 2008 to 28 Feb 2013
The Full Blood Count or FBC is a test that enumerates the different types of cells in a sample of blood and is probably the most commonly performed diagnostic test. We are developing a new platform technology that will enable the FBC to be performed at the Point of Care (PoC). A new generation of low-cost, high technology health monitoring and diagnostic ...
1 Mar 2006 to 31 Oct 2009
Awaiting Public Summary